http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : 최현정 ( Hyun Jeung Choi ) (검색결과 2 건)
- 무료
- 기관 내 무료
- 유료
-
Sunitinib이 갑상선 유두암 세포주의 성장 및 침습에 미치는 영향
한두희 ( Doo Hee Han ),최현정 ( Hyun-jeung Choi ),김원구 ( Won Gu Kim ),김의영 ( Eui Young Kim ),김태용 ( Tae Yong Kim ),김원배 ( Won Bae Kim ),송영기 ( Young Kee Shong ),윤종호 ( Jong Ho Yoon ) 대한갑상선학회 2009 International Journal of Thyroidology Vol.2 No.2
Background and Objectives: Thyroid papillary cancer was known to have a good prognosis but it could have poor prognosis if there is local invasion or metastasis. Sunitinib, a multitargeted tyrosine-kinase inhibitor, has been reported to have an anticancer effect in experimental and clinical studies. In this study, we evaluated the effect of sunitinib on cell growth, migration, adherence in papillary thyroid cancer cell. Materials and Methods: We have evaluated the effect of sunitinib on TPC-1 (papillary thyroid cancer cell) and NPA (melanoma cell). Expression of target gene was evaluated by reverse transcriptase polymerase chain reaction (RT-PCR) and immunoblot. Cell viability was measured by colorimetric assay and invasiveness of cancer cell was measured by migration assay and by anchorage independent growth assay. The change of protein level associated with cell proliferation and cell cycle were evaluated by immunoblot assay. Results: The expression of vascular endothelial growth factor receptor 2 (VEGFR2) and platelet derived growth factor receptor (PDGFR) were more prominent in NPA cell than TPC-1 cell. The proliferation of cancer cells were decreased by sunitinib in dose-dependent manner and NPA cell was more susceptible to sunitinib. The migration and anchoring dependent growth of cancer cells were more decreased in NPA cell by sunitinib. Cyclin inhibitor, p21<sup>Waf1/Cip1</sup> and p27<sup>Kip1</sup> were suppressed by sunitinib only in TPC-1 cell, but not in NPA cell. Conclusion: Sunitinib suppressed cancer cell proliferation and migration in NPA and TPC-1 cell. Sunitinib was less sensitive in papillary thyroid cancer cell than malignant melanoma cell. This difference could be related with suppression of p21<sup>Waf1/Cip1</sup> and p27<sup>Kip1</sup> by sunitinib in TPC-1 cell.
-
내비분비-대사 ; Sunitinib이 FRTL-5 세포의 증식 및 생존에 미치는 영향
김원배 ( Won Bae Kim ),김진아 ( Jin A Kim ),김태용 ( Tae Yong Kim ),송영기 ( Young Kee Shong ),한지민 ( Ji Min Han ),최현정 ( Hyun Jeung Choi ),임지혜 ( Ji Hye Yim ),김언구 ( Won Gu Kim ),김읭여 ( Eui Young Kim ) 대한내과학회 2010 대한내과학회지 Vol.79 No.5
목적: 최근 소화기 기질 종양과 신장암의 치료에 사용되고 있는 표적 치료제인 sunitinib은 36~85%의 환자에서 갑상선 기능 이상을 유발하였다. 아직 sunitinib이 갑상선 기능 저하를 일으키는 기전은 명확히 알려진 바가 없다. 본 연구에서는 현재 가장 널리 사용되고 있는 정상 갑상선 세포 모델인 FRTL-5 세포를 이용하여 sunitinib이 갑상선 세포에 미치는 영향을 확인하고자 하였다. 방법: FRTL-5 세포에서 sunitinib이 세포의 증식에 미치는 영향을 갑상선 자극 호르몬(TSH)의 유무에 따라서 확인하였다. 유속 세포 측정 분석을 통해서 세포 주기에 미치는 영향과 세포 자연사의 여부를 확인하였다. 세포 주기의 진행과 관련된 단백 발현량의 변화는 웨스턴 블롯을 통해서 확인하였다. 결과: Sunitinib은 농도와 시간 의존적으로 FRTL-5 세포의 증식을 억제하였으며, TSH가 존재하는 조건에서 그 영향이 뚜렷하였다. FRTL-5의 세포 주기는 sunitinib에 의해서 G1-S기에 멈추었으며, 15 μM의 고농도에서는 caspase-3를 활성화 하고 세포의 자연사를 촉진하였다. TSH에 의해서 기저에서 억제되어 있었던 p21cip1과 p27kip1의 단백 발현이 sunitinib에 의해서 증가되는 것을 웨스턴 블롯으로 확인하였다. 또한, G1-S기 진행에 관련된 cyclin D1, cyclin dependent kinase 2는 sunitinib에 의해서 억제되었다. 결론: 정상 갑상선 세포주인 FRTL-5 세포는 TSH가 존재하는 상태에서 sunitinib에 의해서 세포의 증식을 더욱 억제 하였고, 고농도에서는 세포 자연사를 유발하였다. Sunitinib은 TSH에 의해서 기존에 억제되어 있던 p27kip1/p21cip1 단백발현을 증가시키면서 세포 주기를 G1-S기에 멈추도록 하였으며, 이는 sunitinib이 TSH의 작용을 방해할 수 있음을 보여주고 있다. Background/Aims: Hypothyroidism has been reported in 36~85% of patients treated with sunitinib for renal cell carcinoma or gastrointestinal stromal tumor. However, the mechanism behind this hypothyroidism is unclear. This study evaluated the effects of sunitinib, a multi-target tyrosine kinase inhibitor, on the survival and proliferation of thyrocytes using FRTL-5 rat thyroid cells. Methods: We examined the effect of sunitinib on cell proliferation in the presence and absence of thyroid stimulating hormone (TSH) in a colorimetric assay. Effects on the cell cycle were evaluated by flow cytometry, and on apoptosis using an annexin V apoptosis assay kit and by immunoblotting for caspase-3. Immunoblotting was also used to evaluate changes in the levels of intracellular proteins associated with the G1-S phase of the cell cycle. Results: Sunitinib suppressed the proliferation of FRTL-5 cells in a dose- and time-dependent manner. This suppressive effect was enhanced by the presence of TSH (1 mU/mL). Sunitinib was subsequently shown, in flow cytometric analyses, to arrest the cell cycle at the G1-S phase. Furthermore, it induced apoptosis at a high concentration (15 μM) by activating caspase-3. G1-S phase arrest was associated with the induction of p27kip1 and p21cip1, whose expression is suppressed by TSH under control conditions. Sunitinib also decreased intracellular levels of cyclin D1 and cyclin-dependent kinase 2 in FRTL-5 cells. Conclusions: Sunitinib induced apoptosis in and suppressed the proliferation of FRTL-5 cells. Its suppression of proliferation was further enhanced by the presence of TSH. Sunitinib arrested the cell cycle in the G1-S phase by inducing the expression of p27kip1/p21cip1, which are suppressed by TSH under normal conditions. Collectively, these findings suggest that sunitinib may interfere with TSH signaling pathways in normal thyrocytes. (Korean J Med 79:509-517, 2010)
KCI연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
